1. Home
  2. OSPN vs CCCC Comparison

OSPN vs CCCC Comparison

Compare OSPN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneSpan Inc.

OSPN

OneSpan Inc.

HOLD

Current Price

$15.52

Market Cap

500.5M

Sector

Technology

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.68

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSPN
CCCC
Founded
1991
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
500.5M
404.7M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
OSPN
CCCC
Price
$15.52
$3.68
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$12.20
AVG Volume (30 Days)
373.6K
4.0M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
4.53%
N/A
EPS Growth
28.77
16.45
EPS
0.30
N/A
Revenue
$243,180,000.00
$35,947,000.00
Revenue This Year
$3.22
N/A
Revenue Next Year
$3.16
N/A
P/E Ratio
$51.88
N/A
Revenue Growth
N/A
1.02
52 Week Low
$10.07
$1.69
52 Week High
$16.41
$5.17

Technical Indicators

Market Signals
Indicator
OSPN
CCCC
Relative Strength Index (RSI) 65.40 42.38
Support Level $14.95 $2.10
Resistance Level $16.09 $3.89
Average True Range (ATR) 0.53 0.37
MACD 0.05 -0.10
Stochastic Oscillator 73.87 15.03

Price Performance

Historical Comparison
OSPN
CCCC

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. The company build secure, seamless, and trusted digital experiences through two solution portfolios: Cybersecurity solutions engaged in protecting identities, securing mobile apps, and safeguarding access through high-assurance authentication, threat intelligence, fraud prevention, and robust mobile app protection, defending users, devices, and applications against sophisticated attacks, while Digital agreement solutions focuses on streamlining workflows with secure e-signatures, identity verification, and smart digital forms, built to enable speed, compliance and other customer experiences.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: